ConforMIS Inc. (NASDAQ:CFMS)’s share price shot up 4% on Thursday . The stock traded as high as $7.38 and last traded at $7.26, with a volume of 138,588 shares changing hands. The stock had previously closed at $6.98.

Several research firms have weighed in on CFMS. Canaccord Genuity reaffirmed a “buy” rating on shares of ConforMIS in a research report on Saturday, May 14th. Oppenheimer Holdings Inc. began coverage on ConforMIS in a research report on Saturday, May 14th. They issued a “buy” rating for the company. Zacks Investment Research raised ConforMIS from a “sell” rating to a “hold” rating in a research report on Friday, July 1st. Deutsche Bank AG dropped their target price on ConforMIS from $26.00 to $12.00 and set a “buy” rating for the company in a research report on Friday, May 13th. Finally, Wells Fargo & Co. downgraded ConforMIS from an “outperform” rating to a “market perform” rating in a research report on Friday, May 13th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $15.20.

The company’s market capitalization is $313.01 million. The company has a 50-day moving average price of $7.12 and a 200 day moving average price of $10.38.

ConforMIS (NASDAQ:CFMS) last posted its quarterly earnings data on Thursday, May 12th. The company reported ($0.37) EPS for the quarter, beating analysts’ consensus estimates of ($0.38) by $0.01. The company had revenue of $20.30 million for the quarter, compared to analyst estimates of $19.23 million. The firm’s quarterly revenue was up 38.1% compared to the same quarter last year. On average, analysts predict that ConforMIS Inc. will post ($1.38) EPS for the current year.

An institutional investor recently raised its position in ConforMIS stock. Wells Fargo & Company MN boosted its position in ConforMIS Inc. (NASDAQ:CFMS) by 38.7% during the fourth quarter, Holdings Channel reports. The firm owned 501,056 shares of the company’s stock after buying an additional 139,708 shares during the period. Wells Fargo & Company MN owned 1.23% of ConforMIS worth $8,663,000 at the end of the most recent quarter.

ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.